AXIOS May 7, 2024
An expanding pipeline of vaccines is giving patients new hope against some of the deadliest cancers, by training the body’s immune system to attack malignancies.
Why it matters: This personalized approach could make conditions like melanoma and bladder, kidney, pancreatic and breast cancers treatable, and even potentially preventable, via infusion.
- But it still can take months to produce a personalized vaccine, giving the cancer more time to spread.
Driving the news: Moderna reported last week that it launched three clinical trials of an experimental mRNA vaccine therapy in patients with bladder cancer, kidney cancer and a form of skin cancer called cutaneous squamous cell carcinoma.
- The company has also embarked on a late-stage trial of how the...
Today's Sponsors
Today's Sponsor